Docoh
Loading...

First Capital Investment

Filed: 8 Dec 20, 9:04am

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 

 

FORM 8-K 

 

CURRENT REPORT 

PURSUANT TO SECTION 13 OR 15(d) 

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): May 4, 2020 

 

StHealth Capital Investment Corporation

(Exact Name of Registrant as Specified in Its Charter) 

 

Maryland814-0113747-1709055
(State or other jurisdiction of(Commission File Number)(I.R.S. Employer
incorporation or organization)Identification No.)
   
 

680 Fifth Ave., 21st Floor

New York, NY 10019

 
 (Address of principal executive offices) 

 

212-601-2769

(Registrant’s telephone number, including area code)

 

N/A 

(Former name or former address, if changed since last report) 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading symbol(s)

Name of each exchange
on which registered

Common stock, par value $0.001 per share

N/A

Not registered on any exchange at this time

Preferred stock, par value $0.001 per share

N/A

Not registered on any exchange at this time

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

   
 

 

Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Resignation of Frederick Alger Boyer, Jr. as Chief Financial Officer, Treasurer and Secretary

 

On December 4, 2020, Frederick Alger Boyer, Jr., the Chief Financial Officer (“CFO”), Treasurer and Secretary of StHealth Capital Investment Corporation (the “Company”) resigned from his positions with the Company, effective as of such date. The departure of Mr. Boyer was not related to any disagreement with the Company’s operations, policies or practices.

 

Appointment of Derek R. Taller as Interim Chief Financial Officer, Treasurer and Secretary

 

On December 4, 2020, the Company named Derek R. Taller, the current President and Chief Executive Officer of the Company, as the interim CFO, Treasurer and Secretary until such time as the Board of Directors (the “Board”) shall ratify and confirm such appointment, or name the permanent replacement of Mr. Boyer.

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Dated: December 7, 2020

 

 StHealth Capital Investment Corporation
  
  
 /s/ Derek Taller 
 Derek Taller
 President & Chief Executive Officer